# FDA Inspection 1044414 - Goetze-Niemer Co Inc - March 08, 2018

Source: https://www.keypedia.com/records/fda_inspections/goetze-niemer-co-inc/10e216bb-84f3-4a4e-b385-8a7d56a3b516
Source feed: FDA_Inspections

> FDA Inspection 1044414 for Goetze-Niemer Co Inc on March 08, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1044414
- Company Name: Goetze-Niemer Co Inc
- Inspection Date: 2018-03-08
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1119118 - 2020-02-05](https://www.keypedia.com/records/fda_inspections/goetze-niemer-co-inc/0256a1ac-83bd-49a9-a1fb-5bbc6ae18d41)
- [FDA Inspection 1044414 - 2018-03-08](https://www.keypedia.com/records/fda_inspections/goetze-niemer-co-inc/62dfa335-ae13-4b20-adf0-550b8c54e99e)
- [FDA Inspection 952168 - 2015-12-14](https://www.keypedia.com/records/fda_inspections/goetze-niemer-co-inc/3c8e260b-e1eb-43e6-a782-7b18d2358939)
- [FDA Inspection 870748 - 2014-03-19](https://www.keypedia.com/records/fda_inspections/goetze-niemer-co-inc/f2752d20-90b9-4cbf-8ff4-600639736e87)

Company: https://www.keypedia.com/companies/goetze-niemer-co-inc/83703be0-a538-4566-9e96-3f3201ddad4a

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d